48,830
edits
(tweak) |
|||
Line 23: | Line 23: | ||
| Prevalence = | | Prevalence = | ||
| Bloodwork = | | Bloodwork = | ||
| Rads = | | Rads = intra-axial mass, +/-calcifications (best seen on CT), nonenhancing or enhancing | ||
| Endoscopy = | | Endoscopy = | ||
| Prognosis = moderate - dependent on grade | | Prognosis = moderate - dependent on grade | ||
Line 36: | Line 36: | ||
**Arise from ''glial precursor cells''. | **Arise from ''glial precursor cells''. | ||
Prognosis by flavours (average survival):<ref name=Ref_PSNP98>{{Ref PSNP|98}}</ref> | |||
*WHO grade II: 10-15 years. | |||
*WHO grade III: 3-5 years. | |||
==Gross/radiologic== | |||
Location: | Location: | ||
*Cerebral hemispheres - most often frontal lobe, followed by parietal and temporal lobes.<ref name=Ref_PSNP94>{{Ref PSNP|94}}</ref> | *Cerebral hemispheres - most often frontal lobe, followed by parietal and temporal lobes.<ref name=Ref_PSNP94>{{Ref PSNP|94}}</ref> | ||
Line 41: | Line 46: | ||
*Intramedullary spinal cord (very rare). | *Intramedullary spinal cord (very rare). | ||
Radiologic features:<ref name=Ref_PSNP94>{{Ref PSNP|94}}</ref> | |||
* | *Intra-axial mass. | ||
* | *+/-Calcifications (best seen on CT). | ||
*Nonenhancing or enhancing. | |||
*Occasionally well-circumscribed. | |||
==Microscopic== | ==Microscopic== |
edits